CONCLUSION
Select molecular mutations in thyroid nodules were associated with specific Bethesda diagnostic categories on cytology. BRAF V600E mutations were mostly associated with Bethesda categories V and VI, whereas RAS and EIF1AX mutations, copy number alterations, and GEP were related to Bethesda categories III and IV. This information may guide clinicians in the prediction of molecular mutations of thyroid nodules and potentially improve management.